Thus, IL-6-related oxidative stress of atherosclerosis counterbalances the antiatherosclerosis effect of GLP-1RA, leading to an aHR of CAD and heart failure with a null effect [30]. The gene discussed is IL6; the disease is coronary artery disorder.